Approved biosimilars have been used in over 121 million days of patient therapy, and these life saving therapies are estimated to provide over $130 billion in savings by 2025.

PATIENT-FIRST MEDICINES

PATIENT-FIRST MEDICINES

Biosimilars, while beneficial to the entire health care system, are for patients first.

JENI'S STORY

HELEN'S STORY

RESOURCES

ACCESSIBLE RESOURCES

Biosimilars increase access to needed treatments. Learn more from these resources.

DELIVERING SAVINGS

SAFE & EFFECTIVE MEDCINES

Often more affordable than reference biologics, FDA-approved biosimilars give millions of people access to these cutting-edge therapies.

Are you or a loved one taking a biosimilar medication?

Sign up for our Introduction to Biosimilars email series and get a more in-depth look into these treatments.